• Drug industry hired dozens of officials from the DEA as the agency tried to curb opioid abuse

    Pharmaceutical companies that manufacture or distribute highly addictive pain pills have hired dozens of officials from the top levels of the Drug Enforcement Administration during the past decade, according to a Washington Post investigation.

    The hires came after the DEA launched an aggressive campaign to curb a rising opioid epidemic that has resulted in thousands of overdose deaths each year. In 2005, the DEA began to crack down on companies that were distributing inordinate numbers of pills such as oxycodone to pain-management clinics and pharmacies around the country.

    Since then, the pharmaceutical companies and law firms that represent them have hired at least 42 officials from the DEA — 31 of them directly from the division responsible for regulating the industry, according to work histories compiled by The Post and interviews with current and former agency officials.

    #pharma #opiacés

    • Patent Monopolies Lead to #Corruption #54,358: The Case of Opioids | Beat the Press | Blogs | Publications | The Center for Economic and Policy Research

      In the case of patent monopolies, the price can increase by a factor or ten or even a hundred, equivalent to a tariff of 1000 or 10,000 percent. The implied mark-ups provide an enormous incentive for companies to lobby to protect and enhance their markets. As the piece tells readers, “each 30-pill vial of oxycodone was worth $900.” If a 30-pill vial was selling for $30, there would have been much less incentive to lobby against legislation that would limit sales.

      For some reason patent monopolies and their role in maintaining high prices for opioids are never mentioned in this piece. It is probably worth mentioning that the Washington Post gets a substantial amount of advertising revenue from the pharmaceutical industry.

      #brevets #publicité